FindTrial
Sign In

Examination of the utility of the fecal microbiota transplantation for Crohn's disease

Examination of the utility of the fecal microbiota transplantation for Crohn's disease - CDFMT

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000024633
Enrollment
40
Registered
2016-11-01
Start date
2016-12-20
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Crohn&#39

Interventions

Fecal microbiota transplantation

Sponsors

Shiga University of Medical Science
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1) Mild to moderate Crohn's disease (2) We are younger than 65 years old 20 years old or older (3) One with CDAI (Crohn's disease disease activity index) 450 or less

Exclusion criteria

Exclusion criteria: (1) Severe Crohn's disease (2) When there are the serious complications including a stenosis and the abscess which expansion needs and the perianal abscess (3) When it is developed an infection with the activity (4) When it is inadequate on the prior examination of the provider (donor) (screening) (5) When we are given antibiotics two weeks before transplant (6) When diabetes and hypertension, hyperlipidemia have other serious complications (7) When we have pregnant possibilities

Design outcomes

Primary

MeasureTime frame
We examine efficacy of the enteric bacteria transfer out of feces for Crohn's disease in 12 weeks.—

Secondary

MeasureTime frame
We examine an adverse event and integrity of the enteric bacteria transfer out of feces.—

Countries

Japan

Contacts

Public ContactHirotsugu Imaeda

Shiga University of Medical Science Division of Gastroenterology, Department of Medicine

imaeda@belle.shiga-med.ac.jp077-548-2217

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026